Explore All 257 Venture Medical Products Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | May 1, 2009 |
| Target | iScience Interventional |
| Sector | Medical Products |
| Investor(s) |
L Capital Partners
Three Arch Partners |
| Deal Type | Venture |
| Deal Value | 21M USD |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2004 |
| PE ASSETS | 165M USD |
| Size | Small |
| Type | Sector Focused |
L Capital Partners is a specialist private equity firm focused on investing in companies operating within the healthcare, technology, and energy/environmental sectors, looking to bring 'groundbreaking products to market'. Within healthcare, L Capital looks to invest in biopharmaceutical and medical device businesses. Within technology, the Firm's emphasis is on security/defense and IT businesses. And within the energy/environmental sector, the L Capital's focus is investing in opportunities that 'improve the quality of life'. L Capital was formed in 2004 and has offices in New York City and Tel Aviv, Israel.
| Deal Context for Investor | # |
|---|---|
| Overall | 15 of 16 |
| Sector: Medical Products | 4 of 4 |
| Type: Venture | 14 of 14 |
| State: California | 3 of 3 |
| Country: United States | 15 of 15 |
| Year: 2009 | 2 of 2 |
| Size (of disclosed) | 2 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-03-01 |
WiSpry
Irvine, California, United States WiSpry, Inc. is a fabless RF semiconductor company that develops RF silicon integrated circuits and components for wireless communication products. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-09 |
Tengion
Winston-Salem, North Carolina, United States Tengion, Inc. is a regenerative medicine company, focuses on discovering, developing, manufacturing, and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues to address unmet medical needs in urologic, renal, gastrointestinal and vascular diseases. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1993 |
| PE ASSETS | 1.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Three Arch Partners is an investor in healthcare companies, including medical devices, diagnostics, and healthcare services. Three Arch primarily invests in early stage companies, however the Firm will consider select later stage investments. Three Arch typically invests alongside others and looks to commit $100k to $15 million per investment. Three Arch Partners was formed in 1993 and is based in San Mateo, California.
| Deal Context for Investor | # |
|---|---|
| Overall | 23 of 27 |
| Sector: Medical Products | 13 of 15 |
| Type: Venture | 20 of 21 |
| State: California | 15 of 16 |
| Country: United States | 22 of 26 |
| Year: 2009 | 1 of 1 |
| Size (of disclosed) | 6 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-07-10 |
Threshold Pharmaceuticals
South San Francisco, California, United States Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-10-20 |
Visiogen
Irvine, California, United States Visiogen has developed an implantable device to improve vision impairment due to age-related presbyopia. |
Sell | $400M |
